Patents by Inventor Jason Wallach

Jason Wallach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLUORINATED TRYPTAMINE COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
    Publication number: 20240286998
    Abstract: The present disclosure relates in one aspect to fluorinated tryptamine compounds, or analogues thereof, and compositions comprising the same. Compounds of the disclosure can be used to treat, prevent, and/or ameliorate a psychiatric disease or disorder in a subject.
    Type: Application
    Filed: June 2, 2022
    Publication date: August 29, 2024
    Inventors: Jason Wallach, Michael Dybek
  • SELECTIVE, PARTIAL, AND ARRESTIN-BIASED 5-HT2A AGONISTS WITH UTILITY IN VARIOUS DISORDERS
    Publication number: 20240254087
    Abstract: Disclosed herein are novel serotonin 5-HT2A receptor agonists with selectivity for the 5-HT2A receptor subtype over other serotonin receptors. Some of these 5-HT2A agonists exhibit functional selectivity and preferentially activate arrestin signaling over G protein-mediated signaling. Also disclosed are pharmaceutical compositions of the compounds and methods of treating certain diseases or conditions.
    Type: Application
    Filed: May 11, 2022
    Publication date: August 1, 2024
    Inventors: Jason WALLACH, John MCCORVY, Adam HALBERSTADT
  • COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS
    Publication number: 20230124101
    Abstract: Provided herein are pharmaceutical formulations and pharmaceutical compound salts which utilize complexing agents as counterions. Such formulations and salts are useful for treating a variety of disease and disorders.
    Type: Application
    Filed: November 4, 2022
    Publication date: April 20, 2023
    Inventors: Jeffrey BECKER, Gregg Peterson, Jason Wallach
  • Complexing agent salt formulations of pharmaceutical compounds
    Patent number: 11534454
    Abstract: Provided herein are pharmaceutical formulations and pharmaceutical compound salts which utilize complexing agents as counterions. Such formulations and salts are useful for treating a variety of disease and disorders.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: December 27, 2022
    Assignee: Bexson Biomedical, Inc.
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach
  • COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS
    Publication number: 20220152088
    Abstract: Provided herein are pharmaceutical formulations and pharmaceutical compound salts which utilize complexing agents as counterions. Such formulations and salts are useful for treating a variety of disease and disorders.
    Type: Application
    Filed: December 9, 2021
    Publication date: May 19, 2022
    Inventors: Jeffrey BECKER, Gregg Peterson, Jason Wallach
  • KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
    Publication number: 20210186896
    Abstract: Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 24, 2021
    Inventors: Jeffrey BECKER, Gregg PETERSON, Jason WALLACH
  • Ketamine formulation for subcutaneous injection
    Patent number: 10973780
    Abstract: Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 13, 2021
    Assignee: Bexson Biomedical, Inc.
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach
  • SYSTEMS, DEVICES, FORMULATIONS AND METHODS FOR CONTROLLED DRUG DELIVERY
    Publication number: 20200384188
    Abstract: Provided herein are systems, devices, formulations, and methods for treating a subject for treating, preventing, or ameliorating at least one symptom of a disorder, disease, or condition according to a controlled dosage regimen to provide effective treatment while reducing the risk of side effects or abuse.
    Type: Application
    Filed: November 14, 2018
    Publication date: December 10, 2020
    Inventors: Jeffrey BECKER, Gregg PETERSON, Jason WALLACH
  • KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
    Publication number: 20200360308
    Abstract: Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
    Type: Application
    Filed: May 14, 2020
    Publication date: November 19, 2020
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach